Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of NaPPS in pediatric patients with mucopolysaccharidosis type VI
jRCT2080223060Phase 2Completed
- Sponsor
- ReqMed Company, Ltd.
- Start
- Jan 2016
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pentosan polysulfate sodium in mucopolysaccharidosis type VI, sponsored by ReqMed Company, Ltd. Started Jan 2016; status: completed.
02
Drugs
pentosan polysulfate sodium
03
Conditions
mucopolysaccharidosis type VI
Beyond the preview
Go deeper on jRCT2080223060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223060.